| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 一种稳定同位素标记碱性橙Ⅱ的合成方法 | CN201310210019.4 | 2013-05-30 | CN103254096B | 2015-11-18 | 徐仲杰; 卢伟京; 卢浩; 李美华; 颜章伟; 江浙 |
| 本发明涉及一种稳定同位素标记碱性橙II的合成方法，以稳定同位素标记苯为原料，经硝化反应生成稳定同位素标记硝基苯，再和还原剂反应，得到稳定同位素标记苯胺，最后经重氮化与间苯二胺耦合转位后得到稳定同位素标记碱性橙II。本发明制备的稳定同位素标记碱性橙II经分离提纯后，化学纯度达98％以上，同位素丰度在98％以上，可充分满足食品安全领域违禁染料检测的需求。 | ||||||
| 2 | 一种稳定同位素标记碱性橙Ⅱ的合成方法 | CN201310210019.4 | 2013-05-30 | CN103254096A | 2013-08-21 | 徐仲杰; 卢伟京; 卢浩; 李美华; 颜章伟; 江浙 |
| 本发明涉及一种稳定同位素标记碱性橙II的合成方法，以稳定同位素标记苯为原料，经硝化反应生成稳定同位素标记硝基苯，再和还原剂反应，得到稳定同位素标记苯胺，最后经重氮化与间苯二胺耦合转位后得到稳定同位素标记碱性橙II。本发明制备的稳定同位素标记碱性橙II经分离提纯后，化学纯度达98％以上，同位素丰度在98％以上，可充分满足食品安全领域违禁染料检测的需求。 | ||||||
| 3 | 一种可光解的三氮烯聚合物 | CN201710207168.3 | 2017-03-31 | CN106967215B | 2019-04-19 | 邓宇; 朱紫红; 郭钟宁; 张永康; 黄志刚; 刘江文; 王文兵; 麦文豪; 洪文生 |
| 本申请属于激光诱导正向转移技术领域，具体涉及一种新型可光解的三氮烯聚合物。本发明所提供的三氮烯聚合物结构新颖可光解，其光吸收峰波长在380nm以上，可有效避免紫外光源对细胞的损伤，满足了将激光诱导正向转移技术应用于生物医学科学实验研究的潜在需求；同时，该类三氮烯聚合物纯度高、溶解度好，发生光解时能均匀的分解成小碎片，在消融羽流中分解成气态产物，不仅不会污染细胞层，而且还会带走细胞层表面残留的固体消融产物，无需额外的清洗步骤。 | ||||||
| 4 | 一种新型可光解的三氮烯聚合物 | CN201710207168.3 | 2017-03-31 | CN106967215A | 2017-07-21 | 邓宇; 朱紫红; 郭钟宁; 张永康; 黄志刚; 刘江文; 王文兵; 麦文豪; 洪文生 |
| 本申请属于激光诱导正向转移技术领域，具体涉及一种新型可光解的三氮烯聚合物。本发明所提供的三氮烯聚合物结构新颖可光解，其光吸收峰波长在380nm以上，可有效避免紫外光源对细胞的损伤，满足了将激光诱导正向转移技术应用于生物医学科学实验研究的潜在需求；同时，该类三氮烯聚合物纯度高、溶解度好，发生光解时能均匀的分解成小碎片，在消融羽流中分解成气态产物，不仅不会污染细胞层，而且还会带走细胞层表面残留的固体消融产物，无需额外的清洗步骤。 | ||||||
| 5 | 性器官肿瘤的靶向化学疗法 | CN200480015022.X | 2004-05-18 | CN1835964A | 2006-09-20 | 汉兹·福斯特尔 |
| 本发明涉及二烷基三氮烯基支撑的雌激素和抗雌激素，它们适合作为治疗人体和动物的性器官癌的化疗药物使用。 | ||||||
| 6 | α- amino acid derivative | JP6268791 | 1991-03-04 | JP2868914B2 | 1999-03-10 | KASE TOMOKO; MYAKE MASAHISA; TAKAHASHI TOSHIHIRO; TAKEDA HIROMITSU; ISHIDA MICHIKO; SHINOZAKI ATSUHIKO |
| 7 | Transition metal complex and production thereof | JP658696 | 1996-01-18 | JPH08231570A | 1996-09-10 | YOTSUHEN DAUTO; UDO PEETSU; BERUNBUARUTO DOIPUTSUAA |
| PROBLEM TO BE SOLVED: To obtain the subject new complex consisting of a triazenide compound obtained by reacting a triazene with a transition metal compound in the presence of a base, and useful as a catalyst for a hydrosilylation reaction of an addition of a Si-bonded hydrogen onto an aliphatic multiple bond. SOLUTION: This transition metal complex is expressed by the formula: M'X' aY' b [M' is Pt, Pd, Rh or Ru; X' is a group of the formula: ANNNR' [R' is a 1-12C hydrocarbon (except an aromatic hydrocarbon in which an aromatic group directly bonded with N), the formula: SiR 6 c(OR 6) 3-c [R 6 is a 1-8C alkyl; (c) is 0, 1, 2, 3]; A is a group of formula I (R 4 is a 1-12C hydrocarbon which may be substituted, a halogen, H, NH 2, NO 2, OH, OR 6, COOH or the like; G is CH or N), formula II, formula III (Q is S, O or NH), formula IV or the like; Y is a halogen, P(C 2H 5) 3, P(C 6H 5) 3, H, pyridine or the like; (a) is 1-4 integer; (b) is 0, 1-6 integer]. The complex is obtained by reacting a triazene of the formula: ANNNHR' with a transition metal compound of the formula: M'Y d ((d) is 1-8 integer). COPYRIGHT: (C)1996,JPO | ||||||
| 8 | Host compound and clathrate compound | JP4817191 | 1991-03-13 | JPH04283528A | 1992-10-08 | TODA FUMIO; TANAKA KOICHI; KAKIGI OSAMU; OKADA TORU; YAGI MINORU |
| PURPOSE: To provide a host compound capable of stably including a guest compound and useful for the production of a clathrate compound which contains triphenylcarbinol group and is useful for the preparation of pharmaceutical agent having excellent sustained releasability of the active component and the durability of the effect. CONSTITUTION: The compound of formula (A is C≡C or N=N; n is 1 or 2; Ph is phenyl). The compound of formula wherein A is C≡C can be produced by using o-, m- or p-bromobenzoic acid of formula II as a starting raw material, reacting according to the reaction formula, reacting the intermediate compound of formula III with methyl o-, m- or p-bromobenzoate and reacting the reaction product with PhMgBr. A clathrate compound can easily be produced by mixing the above compound with a guest compound such as organic solvent, natural essential oil and organic disinfectant at a prescribed ratio at ordinary temperature. COPYRIGHT: (C)1992,JPO&Japio | ||||||
| 9 | OPHTHALMIC LENS MATERIAL AND OPHTHALMIC LENS OF SUCH MATERIAL | US15497211 | 2017-04-26 | US20180210114A1 | 2018-07-26 | HSIU-WEN CHIEN |
| A wetness-retaining ophthalmic lens material comprises an organic monomer, a cross-linking agent, an initiator, a salt, and a solvent. The salt dissolves in the water dissociates a plurality of anions and cations, which bind to water molecules and retard the evaporation of the water molecules, the ophthalmic lens material thus can keep wet for a long time. An ophthalmic lens made of the ophthalmic lens material is also provided. | ||||||
| 10 | Water-soluble polyazo dyestuffs | US555388 | 1995-11-09 | US5597387A | 1997-01-28 | Wolfgang Bauer; Dieter Baumgart; Walter Zoller |
| The present invention relates to water-soluble polyazo dyestuffs of the general formula I ##STR1## wherein Y, Z, m and M.sup..sym.1 to M.sup..sym.4 are as defined in claim 1, processes for dyeing leather and paper with the polyazo dyestuffs, and recording liquids and inks containing the polyazo dyestuffs. | ||||||
| 11 | Preparation of tetraalkyltetrazenes | US65155857 | 1957-04-08 | US3135800A | 1964-06-02 | MCBRIDE WILLIAM R; KRUSE HOWARD W |
| 12 | Azo dyes and preparation and use thereof | US48081 | 1993-04-15 | US5371201A | 1994-12-06 | Rudolf Hurter |
| The invention relates to azo dyes of formula ##STR1## wherein A, B and R.sub.1 are as defined in claim 1. The azo dyes of formula (1) give dyeings of good fastness properties on nitrogen-containing or hydroxy group-containing fibre materials, paper or leather. | ||||||
| 13 | Bistriazene compounds and polymeric compositions crosslinked therewith | US583898 | 1990-09-17 | US5173542A | 1992-12-22 | Aldrich N. K. Lau; Lanchi P. Vo; Frank W. Mercer |
| Bistriazene compounds such as ##STR1## are useful for crosslinking polymers such as poly(imides), poly(aryl ether ketones), poly(aryl ether sulfones), poly(quinolines), poly(quinoxalines), and nonaromatic fluoropolymers having aliphatic C--H groups. Polymers crosslinked with these bistriazene compounds are useful as interlayer insulators in multilayer integrated circuit articles. | ||||||
| 14 | Reaction product of hydrazine and its derivatives with diazophenol and its derivatives, and salts of such products | US32504252 | 1952-12-09 | US2728760A | 1955-12-27 | KENNEY JOSEPH F |
| 15 | Method of manufacturing alkyl tetra Zen | JP2014504379 | 2012-04-12 | JP2014516927A | 2014-07-17 | サバテ，カルロス ミロ; デラル，アンリ; ゲロ，ヤン; ドゥナン，アン; ペリュ，クリスチャン |
| 本発明は、式（I）（式中、R1基またはR2基の一方は、水素、又は1〜6個の炭素原子を含む直鎖状もしくは分岐状アルキル基であり、前記R1基またはR2基の他方は、任意選択で1〜6個の炭素原子を含む直鎖状または分岐状アルキル基である）のアルキルテトラゼンの製造方法であり、前記アルキルテトラゼンの幾つか、特に(E)-1,1,4,4-テトラメチル-2-テトラゼン(TMT)は、プロパルジョンの有利な候補である。 本方法は、式（II）（式中R1及びR2は上記の通り）のヒドラジンのモノクロラミンを用いた酸化（ここで前記酸化は、水性媒体中でpH9〜12.5で行われる）；反応混合物からの有機相の回収（ここで前記有機相は、式(I)のアルキルテトラゼンを含む）；及び、式（I）の前記アルキルテトラゼンの単離を含む。
【選択図】図１ |
||||||
| 16 | Targeted chemotherapy of tumors in the genital | JP2006508181 | 2004-05-18 | JP2006526002A | 2006-11-16 | ハインツ・フェルスター |
| 本発明は、人および動物の生殖器の癌腫を治療するための化学療法薬としての使用に適した、ジアルキルトリアゼンを有するエストロゲンおよび抗エストロゲンに関する。 | ||||||
| 17 | Alpha-amino acid derivative | JP6268791 | 1991-03-04 | JPH04275265A | 1992-09-30 | KASE TOMOKO; MIYAKE MASAHISA; TAKAHASHI TOSHIHIRO; TAKEDA HIROMITSU; ISHIDA MICHIKO; SHINOZAKI ATSUHIKO |
| PURPOSE: To obtain a new compound, an antagonist of inhibitory glycine receptor, useful as a treating agent for non-keto-cis type, an agent for central excitatory state, a medicine similar to strychnine and a physical and chemical reagent. CONSTITUTION: A compound shown by formula I (X is sulfo, 1H-tetrazol-5-yl, etc.; R 1 to R 3 are H, 1-6C alkyl, aralkyl or aryl; R 4 to R 7 are H, halogen, 1-6C lower or 1-6C lower alkoxy; m and n are 1-8), such as 2-amino-3-[2-(2- phosphonomethyl)phenyl]propionic acid. The compound shown by formula I is obtained by hydrolyzing and decarboxylating a compound shown by formula II (Y 1 is 1H-tetrazol-5-yl, etc.; Z is amino-protecting group) under an acidic condition with hydrochloric acid, etc., in a solvent such as acetic acid at 50-120°C for 12-120 hours. COPYRIGHT: (C)1992,JPO&Japio | ||||||
| 18 | Novel physiologically active substance sk-1894 and production thereof | JP4423986 | 1986-03-03 | JPS62205055A | 1987-09-09 | OMURA SATOSHI; KODA HIROSHI; IWAI YUZURU |
| NEW MATERIAL:The compound of formula (the dotted parts are single bonds or double bonds at the same time). USE: It has acylcoenzyme A synthetase inhibiting action and is useful as a preventive and remedy for human diseases caused by the accumulation of neutral fat. PREPARATION: A microbial strain belonging to Streptomyces genus and capable of producing the SK-1894 substance (FERM P-8655) is cultured under aerobic condition to accumulate the physiologically active substance SK-1894C and/or D in the culture product. The product is extracted with a non-hydrophilic organic solvent such as ethyl acetate and the extract is purified to obtain the objective compound of formula having the following properties. Molecular formula, C 11H 19N 3O; molecular weight, 209; specific rotation, [α]D 18=0° (C=1, methanol); solubility, soluble in methanol, acetonitrile, ethyl acetate, etc., and insoluble in water; appearance, pale yellow acicular crystal; nature, neutral, etc. COPYRIGHT: (C)1987,JPO&Japio | ||||||
| 19 | Manufacturing methods and inclusion compound of the clathrate compound | JP4817191 | 1991-03-13 | JP3082264B2 | 2000-08-28 | 稔 八木; 徹 岡田; 芙三夫 戸田; 修 柿木; 耕一 田中 |
| 20 | Catalyst for hydrosilylation reaction, method for activating same, transition metallic complex, its preparation, crosslinkable organopolysiloxane composition and method for reacting organosilicon compound having si-bonded hydrogen atom | JP31318993 | 1993-12-14 | JPH06263780A | 1994-09-20 | YOTSUHEN DAUTO; UDO PEETSU; BERUNBUARUTO DOIPUTSUAA |
| PURPOSE: To obtain a catalyst for hydrosilylation reaction having a specified chemical structure, excellent in catalytic activity and crosslinking ability and suitable for use in the preparation of an organopolysiloxane, etc. CONSTITUTION: The catalyst comprises a compd. of formula I {where M is Pt, Pd, Rh or the like; X is ANNNR, ANNNRR 1, ANNNNA 1 [R is a monovalent (substd.) hydrocarbon or the like; R 1 is H or a monovalent (substd.) hydrocarbon; and each of A and A 1 is a group of formula II (where G is CH or N; and R 4 is a 1-12C monovalent hydrocarbon, halogen, amino, OH or the like) or the like ] or the like; Y is Cl, Br, I, NH 3, P(C 2H 5) 3, H, CO, pyridine, phenylnitrile or the like; (a) is 1-4; and (b) is 0-6}, e.g. Pt[C 6H 5NNNCH 2CH 3] 4. The catalyst is obtd., e.g., by reacting a triazene of formula III (where R' is R) with a transition metallic compd. of formula IV [where M' is Pt, Pd or the like; and (d) is 1-8] in the presence of a base. COPYRIGHT: (C)1994,JPO | ||||||
QQ群二维码
意见反馈
意见反馈